Harvey Jones is feeling the love for his Legal & General shares once again, as the board thrills investors with a new ...

Our writer evaluates the performance of the FTSE 250 in 2024 and considers the prospects of a value stock that may find ...

The Diageo share price has almost halved since peaking in late 2021. But with the stock at a one-year low, I expect a rebound ...

Harvey Jones loves his FTSE 100 dividend income shares but was disappointed by the lack of growth. Now it looks like that may ...

Warnings of weak economic growth, resurgent inflation, and falling interest rates pose a toxic cocktail for Lloyds' share ...

FTSE AIM stock Jet2 appears to be a bargain in plain sight. I’m desperately searching for reasons not to buy this stock, but ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth?

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were ...

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

With sales growth slowing and AI investments weighing on near-term profits, do investors have better stocks to consider buying than Amazon?

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for ...